奧翔藥業(603229.SH):終止前次非公開發行股票事項、撤回申請文件並重新申報
格隆匯 7 月 26日丨奧翔藥業(603229.SH)公佈,公司於2020年7月24日召開第二屆董事會第十九次會議,審議通過了《關於公司終止前次非公開發行股票事項、撤回申請文件並重新申報的議案》。
2020年3月20日,中國證監會發布《發行監管問答——關於上市公司非公開發行股票引入戰略投資者有關事項的監管要求》,對上市公司非公開發行股票引入的戰略投資者提出一系列具體要求。經公司審慎分析並與中介機構等反覆溝通論證,發行人本次非公開發行董事會決議確定的認購對象對於發行人而言不滿足上述關於戰略投資者的相關監管要求。因此,公司擬先向中國證監會申請終止前次非公開發行股票事項、撤回申請文件,並將在修改和調整方案後儘快向中國證監會重新遞交非公開發行的申請材料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.